• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

inflammatory diseases

Living cells illustration Cells membrane with nucleus are floating Medical and science concept background 3D render
Biotech

After $1B fundraise, Xaira breaks silence on AI work

Xaira’s Chief Operating Officer, Jeff Jonker, opened up to Fierce, divulging details about the biotech’s efforts in I&I research.
Gabrielle Masson , Darren Incorvaia Mar 17, 2026 2:52pm
Moon Lake

MoonLake arthritis win kicks off pivotal year for IL-17 nanobody

Feb 23, 2026 5:10am
Healthy foods surrounding chalk drawing of gut

Rasayana Tx ingests GI candidate in $36M deal

Feb 18, 2026 10:40am
A ballpoint pen rests on top of a stack of documents ready for signing

AbbVie hands back phase 1 duties for inflammation drug to Ose

Dec 8, 2025 5:39am
Lung

GSK pens $750M deal for COPD-focused oligonucleotide in phase 1

Oct 28, 2025 6:45am
An artists concept of T cells attacking a cancer cell The T cells are in red while the cancer is light blue The cells are

Nobel winner turns rogue T cells into their own treatment

Oct 23, 2025 10:35am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings